Cori Campbell
DPhil student
I am a DPhil candidate supervised by Prof Philippa Matthews and Prof Ellie Barnes. My background is in epidemiology, and my research is broadly focused on improving characterisation and quantification of Hepatitis B virus (HBV) morbidity and mortality burdens in the United Kingdom. I am interested in identifying novel risk factors for liver cancer and end-stage disease in chronic HBV infection, and in investigating treatment eligibility and coverage across the UK HBV population. I utilise both primary care and secondary care electronic health record databases to undertake my research. My Google Scholar profile can be found here. I am also a Research Officer in the Centre for Social Investigation at Nuffield College.
I’m a Peer Supporter within both the Nuffield Department of Medicine and wider Medical Sciences Division, and am very happy to be contacted with any welfare, wellbeing or related questions or concerns, or just to have an informal chat!
Key publications
-
Analysis of electronic health record data of hepatitis B virus (HBV) patients in primary care: hepatocellular carcinoma (HCC) risk associated with socioeconomic deprivation and reduced by statins
Journal article
Campbell C. et al, (2022)
-
Cohort Profile: National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) Research Dataset
Preprint
Wang T. et al, (2021)
-
Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK
Preprint
Campbell C. et al, (2021)
-
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis.
Journal article
Campbell C. et al, (2021), J Viral Hepat, 28, 493 - 507
Recent publications
-
Hepatitis B Virus (HBV) treatment eligibility in the UK: retrospective longitudinal cohort data to explore the impact of changes in clinical guidelines
Preprint
Campbell C. et al, (2024)
-
Analysis of primary care electronic health record data of people living with hepatitis B virus: infection and hepatocellular carcinoma risk associated with socio-economic deprivation.
Journal article
Campbell C. et al, (2024), Public Health, 226, 215 - 227
-
Classification of virologic trajectories during nucleos/tide analogue treatment of hepatitis B virus (HBV) infection
Preprint
Wang T. et al, (2023)
-
Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya.
Journal article
Downs LO. et al, (2023), J Virus Erad, 9
-
A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) genotypic resistance in people treated with entecavir or tenofovir
Preprint
Lumley SF. et al, (2023)